Author

S. H. Wilks

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. J. Smith· 3 shared A. Netzl· 2 shared F. Krammer· 2 shared S. Tureli· 2 shared A. Carfi· 1 shared A. Jassem· 1 shared A. O. Hassan· 1 shared B. Muhlemann· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

D. J. Smith

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

ImmunologybioRxivJan 28, 2022

Mapping SARS-CoV-2 antigenic relationships and serological responses

S. H. Wilks, B. Muhlemann, X. Shen…·D. J. Smith

The paper uses antigenic cartography to analyze cross-reactivity among SARS-CoV-2 variants and human sera, identifying amino acid substitutions and immunodominance patterns affecting immune escape and vaccine efficacy.

DOI 10.1126/science.adj0070

humanproteomics

𝕏 PostBluesky

ImmunologybioRxivPreprintDec 31, 2021

Combining antigenic data from public sources gives an early indication of the immune escape of emerging virus variants

A. Netzl, S. Tureli, E. LeGresley…·D. J. Smith

The paper aggregates and analyzes antigenic data from multiple sources to assess immune escape of the Omicron BA.1 variant and shows reliable results after one month of data collection.

DOI 10.1101/2021.12.31.474032

statistical modelhost-pathogen & immune response

𝕏 PostBluesky

MicrobiologybioRxivAug 25, 2021

Protective activity of mRNA vaccines against ancestral and variant SARS-CoV-2 strains

B. Ying, B. Whitener, L. A. VanBlargan…·M. S. Diamond

This study evaluates the protective efficacy of mRNA vaccines against SARS-CoV-2 variants in mice, showing that low-dose vaccines lead to breakthrough infections with Delta variant.

DOI 10.1126/scitranslmed.abm3302

mouseexperimental assay

𝕏 PostBluesky